KYMR
KYMERA THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
KYMERA THERAPEUTICS INC (KYMR) is held as common stock by 2 tracked hedge-fund managers, with a combined reported value of ~$1.01B; the largest are Baker Bros. Advisors, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Quiet
Common-stock holders21 also report options
Congress trades0
Price$110.51vs quarter-end-3.63%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew0
Added0
Trimmed / sold1
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $992.73M5.0% of portfolio8,657,2422026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $992.73M | 5.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $3.84M— of portfolio33,5002026 Q2
Value $3.43M— of portfolio29,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $3.84M | — | — |
| Ken GriffinCALL | $3.43M | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.